Literature DB >> 19701803

Neutrophil hyperchemotaxis in Behçet's disease: a possible role for monocytes orchestrating bacterial-induced innate immune responses.

Fabricio Souza Neves1, Solange Carrasco, Cláudia Goldenstein-Schainberg, Célio Roberto Gonçalves, Suzana Beatriz Veríssimo de Mello.   

Abstract

Increased neutrophil chemotaxis and hyperresponsiveness to streptococci have been considered to play a role in Behçet's disease (BD) pathogenesis. Our aim was to correlate TLR2 expression and chemotactic responses stimulated by bacterial lipoteichoic acid (LTA) in BD neutrophils. Thus, we assessed expressions of TLR2 and the correlate receptors CD14, CD114 (G-CSF receptor), CD116 (GM-CSF receptor) and also TLR4 on circulating neutrophils and monocytes of patients with active BD. Serum concentration of soluble CD14 (sCD14) was also measured. Neutrophil chemotactic responses from BD patients and healthy controls under LTA stimulation were assessed. Disease activity was evaluated by Behçet's Disease Current Activity Form (BDCAF). Receptor expressions were measured by flow cytometry, neutrophil chemotaxis was assessed in a Boyden chamber and sCD14 was measured by enzyme-linked immunosorbent assay. TLR2 expression was higher only on BD monocytes compared with healthy controls (39.9 +/- 13.1 vs. 33.6 +/- 5.3, p = 0.019). Expressions of all other receptors were similar in BD and control group. Of particular interest, TLR2 expression on neutrophils was similar in both groups and, when stimulated with LTA, BD neutrophils showed chemotactic responses similar to the controls. Neutrophils exhibited increased chemotaxis only when incubated with BD plasma. Serum sCD14 concentration was higher in BD patients than in controls (1,920.8 +/- 563.6 vs. 1,623.2 +/- 391.3 ng/ml, p = 0.008), and it was positively correlated with both CD14 expression on circulating monocytes membrane (p = 0.035) and BDCAF scores (p = 0.025). In conclusion, isolated BD neutrophils do not overexpress TLR2 neither overreact to LTA. However, because TLR2 expression was higher on BD monocytes, sCD14 from monocyte origin correlated with disease activity and neutrophil hyperchemotaxis occurred on strict dependence of plasmatic soluble factors, we suggest a possible role for bacterial stimulation of monocytes via TLR2 producing neutrophil-stimulating pro-inflammatory factors in BD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19701803     DOI: 10.1007/s10067-009-1261-5

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  38 in total

1.  CD14 and immune response to lipopolysaccharide.

Authors:  C R Maliszewski
Journal:  Science       Date:  1991-05-31       Impact factor: 47.728

2.  Involvement of innate immunity in the pathogenesis of intestinal Behçet's disease.

Authors:  K Nara; M S Kurokawa; S Chiba; H Yoshikawa; S Tsukikawa; T Matsuda; N Suzuki
Journal:  Clin Exp Immunol       Date:  2008-03-10       Impact factor: 4.330

Review 3.  The orchestra of Toll-like receptors and their potential role in frequently occurring rheumatic conditions.

Authors:  Mieke F Roelofs; Shahla Abdollahi-Roodsaz; Leo A B Joosten; Wim B van den Berg; Timothy R D J Radstake
Journal:  Arthritis Rheum       Date:  2008-02

Review 4.  Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease.

Authors: 
Journal:  Lancet       Date:  1990-05-05       Impact factor: 79.321

5.  The effect of prophylactic penicillin treatment on the course of arthritis episodes in patients with Behçet's disease. A randomized clinical trial.

Authors:  M Calgüneri; S Kiraz; I Ertenli; M Benekli; Y Karaarslan; I Celik
Journal:  Arthritis Rheum       Date:  1996-12

6.  Analysis of the effect of an anti-inflammatory steroid, dexamethasone, on neutrophil chemotaxis in the Boyden chamber with a modified 51Cr-labeling method.

Authors:  A Kurihara; F Ojima; S Tsurufuji
Journal:  J Pharmacobiodyn       Date:  1984-10

7.  Leucocyte movement and colchicine treatment in Behcet's disease.

Authors:  N Matsumura; Y Mizushima
Journal:  Lancet       Date:  1975-10-25       Impact factor: 79.321

8.  Neutrophil activation by bacterial lipoprotein versus lipopolysaccharide: differential requirements for serum and CD14.

Authors:  A M Soler-Rodriguez; H Zhang; H S Lichenstein; N Qureshi; D W Niesel; S E Crowe; J W Peterson; G R Klimpel
Journal:  J Immunol       Date:  2000-03-01       Impact factor: 5.422

9.  Neutrophil-potentiating factors released from stimulated lymphocytes; special reference to the increase in neutrophil-potentiating factors from streptococcus-stimulated lymphocytes of patients with Behçet's disease.

Authors:  Y Niwa; Y Mizushima
Journal:  Clin Exp Immunol       Date:  1990-03       Impact factor: 4.330

10.  CD14 is an acute-phase protein.

Authors:  Sylvette Bas; Benoit R Gauthier; Ursula Spenato; Sybille Stingelin; Cem Gabay
Journal:  J Immunol       Date:  2004-04-01       Impact factor: 5.422

View more
  8 in total

Review 1.  Innate immune cells in the pathogenesis of primary systemic vasculitis.

Authors:  Durga Prasanna Misra; Vikas Agarwal
Journal:  Rheumatol Int       Date:  2015-09-24       Impact factor: 2.631

2.  Influence of corticosteroid therapy on IL-18 and nitric oxide production during Behçet's disease.

Authors:  Fatmazohra Djaballah-Ider; Zineb Djeraba; Mourad Chemli; Nadjiba Dammene-Debbihe; Doulkifly Lounis; Houda Belguendouz; Yanis Medour; Samia Chaib; Chafia Touil-Boukoffa
Journal:  Inflammopharmacology       Date:  2018-03-29       Impact factor: 4.473

3.  Genetic Association of a Gain-of-Function IFNGR1 Polymorphism and the Intergenic Region LNCAROD/DKK1 With Behçet's Disease.

Authors:  Lourdes Ortiz Fernández; Patrick Coit; Vuslat Yilmaz; Sibel P Yentür; Fatma Alibaz-Oner; Kenan Aksu; Eren Erken; Nursen Düzgün; Gokhan Keser; Ayse Cefle; Ayten Yazici; Andac Ergen; Erkan Alpsoy; Carlo Salvarani; Bruno Casali; Bünyamin Kısacık; Ina Kötter; Jörg Henes; Muhammet Çınar; Arne Schaefer; Rahime M Nohutcu; Alexandra Zhernakova; Cisca Wijmenga; Fujio Takeuchi; Shinji Harihara; Toshikatsu Kaburaki; Meriam Messedi; Yeong-Wook Song; Timuçin Kaşifoğlu; F David Carmona; Joel M Guthridge; Judith A James; Javier Martin; María Francisca González Escribano; Güher Saruhan-Direskeneli; Haner Direskeneli; Amr H Sawalha
Journal:  Arthritis Rheumatol       Date:  2021-05-18       Impact factor: 15.483

4.  Low density neutrophils are increased in patients with Behçet's disease but do not explain differences in neutrophil function.

Authors:  Mariam Murad; Liying Low; Matthew Davidson; Philip I Murray; Saaeha Rauz; Graham R Wallace
Journal:  J Inflamm (Lond)       Date:  2022-03-31       Impact factor: 4.981

Review 5.  The Potential Role of Trained Immunity in Autoimmune and Autoinflammatory Disorders.

Authors:  Rob J W Arts; Leo A B Joosten; Mihai G Netea
Journal:  Front Immunol       Date:  2018-02-20       Impact factor: 7.561

6.  Soluble CD40L is associated with increased oxidative burst and neutrophil extracellular trap release in Behçet's disease.

Authors:  Sandro Félix Perazzio; Paulo Vitor Soeiro-Pereira; Viviane Cardoso Dos Santos; Marlon Vilela de Brito; Bruno Salu; Maria Luiza Vilela Oliva; Anne Margherite Stevens; Alexandre Wagner Silva de Souza; Hans D Ochs; Troy R Torgerson; Antonio Condino-Neto; Luis Eduardo Coelho Andrade
Journal:  Arthritis Res Ther       Date:  2017-10-19       Impact factor: 5.156

Review 7.  Understanding Behçet's Disease in the Context of Innate Immunity Activation.

Authors:  Sandro F Perazzio; Luis E C Andrade; Alexandre W S de Souza
Journal:  Front Immunol       Date:  2020-10-20       Impact factor: 7.561

Review 8.  Immunopathophysiology and clinical impact of uveitis in inflammatory rheumatic diseases: An update.

Authors:  Elvis Hysa; Carlo Alberto Cutolo; Emanuele Gotelli; Greta Pacini; Carlotta Schenone; Elke O Kreps; Vanessa Smith; Maurizio Cutolo
Journal:  Eur J Clin Invest       Date:  2021-05-05       Impact factor: 4.686

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.